New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis

1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their sa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SCHEEFERS, HANS
Format: Patent
Sprache:eng ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHEEFERS, HANS
description 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. R 1>F, Cl or CF 3; R 2>H or 1-4C-alkyl; and R 3>H, 1-4C-alkyl or OH. Independent claims are included for intermediates comprising 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid and 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid. [Image] [Image] ACTIVITY : Cytostatic; Antiinflammatory; Antiasthmatic; Antiallergic; Ophthalmological; Dermatological; Antiarthritic; Osteopathic; Antirheumatic; Antibacterial; Immunosuppressive; Antidiabetic; Hemostatic; Neuroprotective; Muscular-Gen.; Gastrointestinal-Gen.; Antipsoriatic; Nephrotropic; Respiratory-Gen.; Anabolic; Anorectic; Cardiant. MECHANISM OF ACTION : None given. Die vorliegende Patentanmeldung betrifft neue Pharmazeutika auf der Basis neuartiger Kinase-Inhibitoren, wie beispielsweise $F1.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE102009024296A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE102009024296A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE102009024296A13</originalsourceid><addsrcrecordid>eNqNir1KBDEURqexEPUdbiPswmSZmR2ELUVXrKzsl0tyZxPIH7k36DyzL2EEkS2tvvNxznX39UYfMKrNrLT1qSS1V1Lc4mvjQGJXr7KluPptM63a5LU446Ka1erT57r907UQgk4hpxoNQ2VaqgdJIE0I0O68A41RU-kBWWzAHmoRp7G4hljEFieOe0gslC5-sVQDSnLmsmLK_LNYmwmhRgLjmJCJAaOBUL247AlYeyqptbfd1YKe6e53b7r7l-P706uinE7EGTVFktPzcRymYTgM0zwdHh7H_X-7b_lWcTQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis</title><source>esp@cenet</source><creator>SCHEEFERS, HANS</creator><creatorcontrib>SCHEEFERS, HANS</creatorcontrib><description>1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. R 1&gt;F, Cl or CF 3; R 2&gt;H or 1-4C-alkyl; and R 3&gt;H, 1-4C-alkyl or OH. Independent claims are included for intermediates comprising 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid and 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid. [Image] [Image] ACTIVITY : Cytostatic; Antiinflammatory; Antiasthmatic; Antiallergic; Ophthalmological; Dermatological; Antiarthritic; Osteopathic; Antirheumatic; Antibacterial; Immunosuppressive; Antidiabetic; Hemostatic; Neuroprotective; Muscular-Gen.; Gastrointestinal-Gen.; Antipsoriatic; Nephrotropic; Respiratory-Gen.; Anabolic; Anorectic; Cardiant. MECHANISM OF ACTION : None given. Die vorliegende Patentanmeldung betrifft neue Pharmazeutika auf der Basis neuartiger Kinase-Inhibitoren, wie beispielsweise $F1.</description><language>eng ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101209&amp;DB=EPODOC&amp;CC=DE&amp;NR=102009024296A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101209&amp;DB=EPODOC&amp;CC=DE&amp;NR=102009024296A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHEEFERS, HANS</creatorcontrib><title>New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis</title><description>1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. R 1&gt;F, Cl or CF 3; R 2&gt;H or 1-4C-alkyl; and R 3&gt;H, 1-4C-alkyl or OH. Independent claims are included for intermediates comprising 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid and 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid. [Image] [Image] ACTIVITY : Cytostatic; Antiinflammatory; Antiasthmatic; Antiallergic; Ophthalmological; Dermatological; Antiarthritic; Osteopathic; Antirheumatic; Antibacterial; Immunosuppressive; Antidiabetic; Hemostatic; Neuroprotective; Muscular-Gen.; Gastrointestinal-Gen.; Antipsoriatic; Nephrotropic; Respiratory-Gen.; Anabolic; Anorectic; Cardiant. MECHANISM OF ACTION : None given. Die vorliegende Patentanmeldung betrifft neue Pharmazeutika auf der Basis neuartiger Kinase-Inhibitoren, wie beispielsweise $F1.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNir1KBDEURqexEPUdbiPswmSZmR2ELUVXrKzsl0tyZxPIH7k36DyzL2EEkS2tvvNxznX39UYfMKrNrLT1qSS1V1Lc4mvjQGJXr7KluPptM63a5LU446Ka1erT57r907UQgk4hpxoNQ2VaqgdJIE0I0O68A41RU-kBWWzAHmoRp7G4hljEFieOe0gslC5-sVQDSnLmsmLK_LNYmwmhRgLjmJCJAaOBUL247AlYeyqptbfd1YKe6e53b7r7l-P706uinE7EGTVFktPzcRymYTgM0zwdHh7H_X-7b_lWcTQ</recordid><startdate>20101209</startdate><enddate>20101209</enddate><creator>SCHEEFERS, HANS</creator><scope>EVB</scope></search><sort><creationdate>20101209</creationdate><title>New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis</title><author>SCHEEFERS, HANS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE102009024296A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ger</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHEEFERS, HANS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHEEFERS, HANS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis</title><date>2010-12-09</date><risdate>2010</risdate><abstract>1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. 1-(4-Chloro-3-trifluoromethyl-phenyl)-3-[4-(pyridin-4-yloxy)-phenyl]-urea compounds (Q) of formula (I) or (II), and their salts with counter ions, prodrugs, pyridin-N-oxides or metabolites, are new. R 1&gt;F, Cl or CF 3; R 2&gt;H or 1-4C-alkyl; and R 3&gt;H, 1-4C-alkyl or OH. Independent claims are included for intermediates comprising 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid tert-butyl ester, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-trifluoromethyl-phenoxy}-pyridine-2-carboxylic acid, 4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-3-fluoro-phenoxy}-pyridine-2-carboxylic acid and 4-{3-chloro-4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid. [Image] [Image] ACTIVITY : Cytostatic; Antiinflammatory; Antiasthmatic; Antiallergic; Ophthalmological; Dermatological; Antiarthritic; Osteopathic; Antirheumatic; Antibacterial; Immunosuppressive; Antidiabetic; Hemostatic; Neuroprotective; Muscular-Gen.; Gastrointestinal-Gen.; Antipsoriatic; Nephrotropic; Respiratory-Gen.; Anabolic; Anorectic; Cardiant. MECHANISM OF ACTION : None given. Die vorliegende Patentanmeldung betrifft neue Pharmazeutika auf der Basis neuartiger Kinase-Inhibitoren, wie beispielsweise $F1.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; ger
recordid cdi_epo_espacenet_DE102009024296A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phenyl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A10%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHEEFERS,%20HANS&rft.date=2010-12-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE102009024296A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true